International Journal of Cardiology

Slides:

Advertisements

Similar presentations

Weng TC, et al. J Clin Pharm Ther 2010;35:

Advertisements

Slide Source: Lipid and Lipoprotein Parameters at Baseline and Drug Treatment: METEOR Trial Baseline, Mean (SD) Time-Weighted Average.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

Relation between Cardiovascular Disease Risk Markers and Brain Infarcts Detected by Magnetic Resonance Imaging in an Elderly Population Ruta Nylander,

Copyright © 2017 American Academy of Pediatrics.

Copyright © 2007 American Medical Association. All rights reserved.

Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients.

DOI: /j.atherosclerosis

Copyright © 2012 American Medical Association. All rights reserved.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Volume 148, Issue 4, Pages (April 2015)

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis? Sripal Bangalore, MD,

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis Sarah A. Anderson, John.

Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY.

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

Plasma cystathionine and risk of acute myocardial infarction among patients with coronary heart disease: Results from two independent cohorts Indu Dhar,

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report Terry A. Jacobson, MD, Matthew K. Ito,

Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:

Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles Jan.

A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia Gisle Langslet, MD, Andrei Breazna, PhD, Euridiki.

Fellström BC, et al. N Engl J Med 2009;360:1455-7

Jonathan C. Cohen, PhD Journal of Clinical Lipidology

J. W. Balder, MD, PhD, P. J. Lansberg, MD, PhD, M. H. Hof, MSc, A

Meredith Kilgore, PhD, Paul Muntner, PhD, J

II. assessment of dyslipidemias

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Cardiovascular disease in women with HIV-1 infection

Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases Eirik Ikdahl, Grunde Wibetoe,

Paul D. Thompson, MD, John Rubino, MD, Matthew J. Janik, MD, Diane E

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

I. Introduction American Journal of Kidney Diseases

Task-sharing interventions for cardiovascular risk reduction and lipid outcomes in low- and middle-income countries: A systematic review and meta-analysis

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical.

Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles Jan.

Hazard ratios for the primary end point by subgroup of achieved LDL cholesterol (adjusted for age, sex, baseline calculated LDL cholesterol, diabetes,

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Lipid Profiles in Out-of-Hospital Sudden Unexpected Death

Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment Robert Dufour,

International Journal of Cardiology

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition.

Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with.

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study Hubert Scharnagl,

Bouwe P. Krijthe, Maarten J. G. Leening, Jan Heeringa, Jan A

Sokunthea Peou, PharmD, Brittany Milliard-Hasting, MD, Sachin A

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Anne L. M. Vlek, MD, Yolanda van der Graaf, MD, PhD, Maayke A

Baseline Characteristics of the Subjects*

Elevated High-Density Lipoprotein Cholesterol Is Associated with Hyponatremia in Hypertensive Patients Ariel Israel, MD, PhD, Ehud Grossman, MD The.

Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008 Sanne M. Snelder, Sjoerd T. Nauta,

Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into.

International Journal of Cardiology

Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

The ACCORD Study Group. NEJM 2010; Epub March 14

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Adjusted relative risk Adjusted odds ratio

III. Treating dyslipidemias

Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.

Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.

International Journal of Cardiology

Differences in changes in total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides (expressed as mg/dL) between patients with hyperlipidaemia.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

International Journal of Cardiology Lipid levels achieved after a first myocardial infarction and the prediction of recurrent atherosclerotic cardiovascular disease Joel Ohm, Paul Hjemdahl, Per H. Skoglund, Andrea Discacciati, Johan Sundström, Kristina Hambraeus, Tomas Jernberg, Per Svensson International Journal of Cardiology DOI: 10.1016/j.ijcard.2019.07.001 Copyright © 2019 Elsevier B.V. Terms and Conditions

Fig. 1 Forest plots depicting group-level hazard ratios with 95% confidence intervals for rASCVD by quintiles of LDL-C (panel A), TC (panel B), HDL-C (panel C), and TGs (panel D). Panel E depicts model I-II hazard ratios by categories of LDL-C. Abbreviations: LDL-C, low density lipoprotein cholesterol; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; TGs, triglycerides. To convert LDL-C, TC, or HDL-C values to mg/dL, multiply by 38.67. To convert TG values to mg/dL, multiply by 88.57. Model I was crude. Model II was adjusted for age, gender, and year of baseline revisit. International Journal of Cardiology DOI: (10.1016/j.ijcard.2019.07.001) Copyright © 2019 Elsevier B.V. Terms and Conditions